Stock
Quantum Biopharma Ltd. Class B Subordinate Voting Shares QNTM
Overview
QNTM market data
Price History
QNTM price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$7.97 Diluted earnings per share over the trailing twelve months.
- Beta
- 5.27 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.85 – $43.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $25.6 · P/S 109.25.
Company News
Reported Earlier, Quantum BioPharma Approves Debt Settlement Of C$123,487.43 Via Class B Shares At Deemed Price Of C$4.26 Or LowerBenzinga · Jul 21, 2026, 6:53 AM
Quantum BioPharma Announces Intention to Settle DebtGlobenewswire Inc · Jul 20, 2026, 11:30 PM
Trading Halt: Halt status updated at 7:05:00 AM ET: Quotation Resumption: News and Resumption TimesBenzinga · Jun 2, 2026, 11:05 AM
Trading Halt: Halted at 7:25:00 p.m. ET - Trading Halt: Halt News PendingBenzinga · Jun 1, 2026, 11:25 PM